MEGAN CROSIER: Open Payments
NPI 1902459555 · MEMPHIS, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,604 in 76 payments from 27 companies in 2025. Trend: 2023 $2,446 · 2024 $2,219 · 2025 $1,604
Food & beverage: $1,524Education: $80
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 7 | $170 |
| Novartis Pharmaceuticals Corporation | 7 | $155 |
| PFIZER INC. | 7 | $135 |
| Celgene Corporation | 5 | $131 |
| ABBVIE INC. | 5 | $111 |
| E.R. Squibb & Sons, L.L.C. | 6 | $107 |
| Gilead Sciences, Inc. | 4 | $85 |
| Merck Sharp & Dohme LLC | 4 | $84 |
| GlaxoSmithKline, LLC. | 4 | $80 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $74 |
Products named: KISQALI, REBLOZYL, Trodelvy, KEYTRUDA, DARZALEX, ERLEADA, OPDIVO, XTANDI.
Industry payments across TN — which companies pay providers there.
